I think if it was all doughnuts (no significant differences on any of the outcomes) then it would be straightforward and would be released.
And similarly if it was strongly positive, it would also be relatively straightforward. Bear in mind its a small study so to show a strong positive significant result was going to be difficult statistically.
So, wishful thinking tells me there might be something there worth exploring in between those two outcomes.
They might be getting another statistician's opinion.
Because if there is something there, they need to be careful because the impact of a positive finding on the share price would be extremely positive.
- Forums
- ASX - By Stock
- FRE
- Ann: Update on Nasodine Phase 2 Study
FRE
firebrick pharma limited
Add to My Watchlist
14.3%
!
6.0¢

Ann: Update on Nasodine Phase 2 Study, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.0¢ |
Change
-0.010(14.3%) |
Mkt cap ! $13.47M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.0¢ | $14.43K | 234.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 50062 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 1716 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50062 | 0.061 |
2 | 214685 | 0.060 |
2 | 30000 | 0.059 |
1 | 100000 | 0.057 |
2 | 143832 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 1716 | 1 |
0.080 | 47101 | 2 |
0.088 | 5758 | 2 |
0.089 | 15000 | 1 |
0.090 | 100 | 1 |
Last trade - 14.40pm 26/06/2025 (20 minute delay) ? |
Featured News
FRE (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online